Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

9. Arm lymphoedema following breast cancer treatment

Identifieur interne : 000194 ( PascalFrancis/Curation ); précédent : 000193; suivant : 000195

9. Arm lymphoedema following breast cancer treatment

Auteurs : A. Sparaco [Royaume-Uni] ; I. S. Fentiman [Royaume-Uni]

Source :

RBID : Pascal:02-0389977

Descripteurs français

English descriptors

Abstract

Lymphoedema of the upper limb can be a devastating consequence of breast cancer treatment. A wide range of incidence has been reported but the generally accepted rate is around 12%. The exact pathophysiological mechanisms remain unclear. Agreed working definitions are required in order to standardise future research in this area. The psychosocial importance and management is fundamental in limiting the impact of this phenomenon. Furthermore, it remains that the primary cause is dissection of the axilla. Therefore, active investigation into potential tools that may eliminate or reduce the extent of dissection without compromising prognosis is warranted.
pA  
A01 01  1    @0 1368-5031
A03   1    @0 Int. j. clin. pract. : (Esher)
A05       @2 56
A06       @2 2
A08 01  1  ENG  @1 9. Arm lymphoedema following breast cancer treatment
A11 01  1    @1 SPARACO (A.)
A11 02  1    @1 FENTIMAN (I. S.)
A14 01      @1 Hedley Atkins Breast Unit, Guy's Hospital @2 London @3 GBR @Z 1 aut. @Z 2 aut.
A20       @1 107-110
A21       @1 2002
A23 01      @0 ENG
A43 01      @1 INIST @2 15561 @5 354000101413400080
A44       @0 0000 @1 © 2002 INIST-CNRS. All rights reserved.
A45       @0 30 ref.
A47 01  1    @0 02-0389977
A60       @1 P
A61       @0 A
A64 01  1    @0 International journal of clinical practice : (Esher)
A66 01      @0 GBR
C01 01    ENG  @0 Lymphoedema of the upper limb can be a devastating consequence of breast cancer treatment. A wide range of incidence has been reported but the generally accepted rate is around 12%. The exact pathophysiological mechanisms remain unclear. Agreed working definitions are required in order to standardise future research in this area. The psychosocial importance and management is fundamental in limiting the impact of this phenomenon. Furthermore, it remains that the primary cause is dissection of the axilla. Therefore, active investigation into potential tools that may eliminate or reduce the extent of dissection without compromising prognosis is warranted.
C02 01  X    @0 002B20E02
C03 01  X  FRE  @0 Tumeur maligne @5 01
C03 01  X  ENG  @0 Malignant tumor @5 01
C03 01  X  SPA  @0 Tumor maligno @5 01
C03 02  X  FRE  @0 Glande mammaire @5 02
C03 02  X  ENG  @0 Mammary gland @5 02
C03 02  X  SPA  @0 Glándula mamaria @5 02
C03 03  X  FRE  @0 Lymphoedème @5 04
C03 03  X  ENG  @0 Lymphedema @5 04
C03 03  X  SPA  @0 Linfedema @5 04
C03 04  X  FRE  @0 Membre supérieur @5 07
C03 04  X  ENG  @0 Upper limb @5 07
C03 04  X  SPA  @0 Miembro superior @5 07
C03 05  X  FRE  @0 Traitement @5 10
C03 05  X  ENG  @0 Treatment @5 10
C03 05  X  SPA  @0 Tratamiento @5 10
C03 06  X  FRE  @0 Chirurgie @5 11
C03 06  X  ENG  @0 Surgery @5 11
C03 06  X  SPA  @0 Cirugía @5 11
C03 07  X  FRE  @0 Complication @5 12
C03 07  X  ENG  @0 Complication @5 12
C03 07  X  SPA  @0 Complicación @5 12
C03 08  X  FRE  @0 Pathogénie @5 13
C03 08  X  ENG  @0 Pathogenesis @5 13
C03 08  X  SPA  @0 Patogenia @5 13
C03 09  X  FRE  @0 Prévention @5 14
C03 09  X  ENG  @0 Prevention @5 14
C03 09  X  SPA  @0 Prevención @5 14
C03 10  X  FRE  @0 Homme @5 16
C03 10  X  ENG  @0 Human @5 16
C03 10  X  SPA  @0 Hombre @5 16
C03 11  X  FRE  @0 Femelle @5 17
C03 11  X  ENG  @0 Female @5 17
C03 11  X  SPA  @0 Hembra @5 17
C07 01  X  FRE  @0 Glande mammaire pathologie @2 NM @5 37
C07 01  X  ENG  @0 Mammary gland diseases @2 NM @5 37
C07 01  X  SPA  @0 Glándula mamaria patología @2 NM @5 37
C07 02  X  FRE  @0 Appareil circulatoire pathologie @5 45
C07 02  X  ENG  @0 Cardiovascular disease @5 45
C07 02  X  SPA  @0 Aparato circulatorio patología @5 45
C07 03  X  FRE  @0 Lymphatique pathologie @5 46
C07 03  X  ENG  @0 Lymphatic vessel disease @5 46
C07 03  X  SPA  @0 Linfático patología @5 46
N21       @1 217
N82       @1 PSI

Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:02-0389977

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">9. Arm lymphoedema following breast cancer treatment</title>
<author>
<name sortKey="Sparaco, A" sort="Sparaco, A" uniqKey="Sparaco A" first="A." last="Sparaco">A. Sparaco</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Hedley Atkins Breast Unit, Guy's Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author>
<name sortKey="Fentiman, I S" sort="Fentiman, I S" uniqKey="Fentiman I" first="I. S." last="Fentiman">I. S. Fentiman</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Hedley Atkins Breast Unit, Guy's Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">02-0389977</idno>
<date when="2002">2002</date>
<idno type="stanalyst">PASCAL 02-0389977 INIST</idno>
<idno type="RBID">Pascal:02-0389977</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000766</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000194</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">9. Arm lymphoedema following breast cancer treatment</title>
<author>
<name sortKey="Sparaco, A" sort="Sparaco, A" uniqKey="Sparaco A" first="A." last="Sparaco">A. Sparaco</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Hedley Atkins Breast Unit, Guy's Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author>
<name sortKey="Fentiman, I S" sort="Fentiman, I S" uniqKey="Fentiman I" first="I. S." last="Fentiman">I. S. Fentiman</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Hedley Atkins Breast Unit, Guy's Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">International journal of clinical practice : (Esher)</title>
<title level="j" type="abbreviated">Int. j. clin. pract. : (Esher)</title>
<idno type="ISSN">1368-5031</idno>
<imprint>
<date when="2002">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">International journal of clinical practice : (Esher)</title>
<title level="j" type="abbreviated">Int. j. clin. pract. : (Esher)</title>
<idno type="ISSN">1368-5031</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Complication</term>
<term>Female</term>
<term>Human</term>
<term>Lymphedema</term>
<term>Malignant tumor</term>
<term>Mammary gland</term>
<term>Pathogenesis</term>
<term>Prevention</term>
<term>Surgery</term>
<term>Treatment</term>
<term>Upper limb</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Tumeur maligne</term>
<term>Glande mammaire</term>
<term>Lymphoedème</term>
<term>Membre supérieur</term>
<term>Traitement</term>
<term>Chirurgie</term>
<term>Complication</term>
<term>Pathogénie</term>
<term>Prévention</term>
<term>Homme</term>
<term>Femelle</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Chirurgie</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Lymphoedema of the upper limb can be a devastating consequence of breast cancer treatment. A wide range of incidence has been reported but the generally accepted rate is around 12%. The exact pathophysiological mechanisms remain unclear. Agreed working definitions are required in order to standardise future research in this area. The psychosocial importance and management is fundamental in limiting the impact of this phenomenon. Furthermore, it remains that the primary cause is dissection of the axilla. Therefore, active investigation into potential tools that may eliminate or reduce the extent of dissection without compromising prognosis is warranted.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>1368-5031</s0>
</fA01>
<fA03 i2="1">
<s0>Int. j. clin. pract. : (Esher)</s0>
</fA03>
<fA05>
<s2>56</s2>
</fA05>
<fA06>
<s2>2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>9. Arm lymphoedema following breast cancer treatment</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>SPARACO (A.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>FENTIMAN (I. S.)</s1>
</fA11>
<fA14 i1="01">
<s1>Hedley Atkins Breast Unit, Guy's Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA20>
<s1>107-110</s1>
</fA20>
<fA21>
<s1>2002</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>15561</s2>
<s5>354000101413400080</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2002 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>30 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>02-0389977</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>International journal of clinical practice : (Esher)</s0>
</fA64>
<fA66 i1="01">
<s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Lymphoedema of the upper limb can be a devastating consequence of breast cancer treatment. A wide range of incidence has been reported but the generally accepted rate is around 12%. The exact pathophysiological mechanisms remain unclear. Agreed working definitions are required in order to standardise future research in this area. The psychosocial importance and management is fundamental in limiting the impact of this phenomenon. Furthermore, it remains that the primary cause is dissection of the axilla. Therefore, active investigation into potential tools that may eliminate or reduce the extent of dissection without compromising prognosis is warranted.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B20E02</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Tumeur maligne</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Malignant tumor</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Tumor maligno</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Glande mammaire</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Mammary gland</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Glándula mamaria</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Lymphoedème</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Lymphedema</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Linfedema</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Membre supérieur</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Upper limb</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Miembro superior</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Traitement</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Treatment</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Tratamiento</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Chirurgie</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Surgery</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Cirugía</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Complication</s0>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Complication</s0>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Complicación</s0>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Pathogénie</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Pathogenesis</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Patogenia</s0>
<s5>13</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Prévention</s0>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Prevention</s0>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Prevención</s0>
<s5>14</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Homme</s0>
<s5>16</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Human</s0>
<s5>16</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>16</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>Femelle</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG">
<s0>Female</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA">
<s0>Hembra</s0>
<s5>17</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Glande mammaire pathologie</s0>
<s2>NM</s2>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Mammary gland diseases</s0>
<s2>NM</s2>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Glándula mamaria patología</s0>
<s2>NM</s2>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Appareil circulatoire pathologie</s0>
<s5>45</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Cardiovascular disease</s0>
<s5>45</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Aparato circulatorio patología</s0>
<s5>45</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Lymphatique pathologie</s0>
<s5>46</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Lymphatic vessel disease</s0>
<s5>46</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Linfático patología</s0>
<s5>46</s5>
</fC07>
<fN21>
<s1>217</s1>
</fN21>
<fN82>
<s1>PSI</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000194 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000194 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:02-0389977
   |texte=   9. Arm lymphoedema following breast cancer treatment
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024